Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Novel agent shown to have dual mechanism of action to eliminate cancer

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.

11 Jun 2019

Complex molecular conversation is key to the establishment of 'hot tumor'

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

11 Jun 2019

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

11 Jun 2019

Radiation associated with increased risk of adverse cardiac events in lung cancer patients

As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure.

11 Jun 2019

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.

11 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Tart cherry reduces the musculoskeletal effects of aromatase inhibitors in patients with non-metastatic breast cancer, according to new findings from a clinical trial by researchers at Marshall University Joan C. Edwards School of Medicine and Edwards Comprehensive Cancer Center.

10 Jun 2019

Novel radiotracer can identify nearly 30 types of malignant tumors

A novel class of radiopharmaceuticals has proven effective in non-invasively identifying nearly 30 types of malignant tumors, according to research published in the June issue of The Journal of Nuclear Medicine.

10 Jun 2019

Continuous personnel changes are a major cause of NHS ultrasound staff shortage, shows study

A new study of ultrasound departments shows that continuous personnel changes are a major cause of the now serious shortage of ultrasound staff in the NHS.

10 Jun 2019

World’s first clinical guidance on anal sex after prostate cancer treatments

UK doctors and surgeons have formulated what is probably the world's first clinical guidance on anal sex before, during, and after diagnosis and treatment for prostate cancer.

10 Jun 2019

Researchers propose a new look at the role of ferroptosis in cancer development

Professor of Ghent University and Lead Researcher at the Institute of Biology and Biomedicine of the Lobachevsky University Dmitri Krysko together with scientists from Germany, Professor Marcus Conrad and Professor Jose Pedro Friedmann Angeli recently published an article in the journal Nature Reviews Cancer, one of the highest-rated journals that occupies the 2nd line in the oncology section among 223 journals in this category and has an impact factor of 42.78 according to WoS data.

7 Jun 2019

Robotic surgery for oropharyngeal cancer not better than radiation therapy, study finds

In 2012, scientists at Lawson Health Research Institute launched the world's first clinical trial comparing robotic surgery to radiation therapy for the treatment of oropharyngeal cancer (cancer at the back of the throat).

7 Jun 2019

Three-drug combination could be effective therapy for people with advanced melanoma

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

7 Jun 2019

ASTRO applauds new prior authorization legislation that aims to reduce obstacles in cancer care

On behalf of the nation's radiation oncologists and the more-than one million cancer patients in their care this year, the American Society for Radiation Oncology applauded today's introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices that unnecessarily delay patient access to critical cancer treatments.

6 Jun 2019

Vitamin D could extend lifespan of cancer patients

Michigan State University physicians have found that vitamin D, if taken for at least three years, could help cancer patients live longer.

4 Jun 2019

Promega launches MSI educational website

Researchers and clinicians seeking to deepen their understanding of Microsatellite Instability have a new resource gathering information in one place.

From Promega Corporation 4 Jun 2019

MammaPrint and BluePrint identify critical aspects of tumor biology in African-American breast cancer patients

Agendia, Inc., a world leader in precision oncology, today announced the presentation of study results for BluePrint and MammaPrint use in identifying African-American women with hormone receptor positive tumors that have different genomic subtypes and risk than Caucasian women.

4 Jun 2019

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Tumors arise when cells shake off their restraints and start to multiply out of control. But how fast a tumor grows does not depend solely on how quickly the cancer cells can divide, a new study has found.

4 Jun 2019

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.

4 Jun 2019

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.

3 Jun 2019

Oncology News and Research

Further Reading

Novel agent shown to have dual mechanism of action to eliminate cancer

Complex molecular conversation is key to the establishment of 'hot tumor'

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

Radiation associated with increased risk of adverse cardiac events in lung cancer patients

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Novel radiotracer can identify nearly 30 types of malignant tumors

Continuous personnel changes are a major cause of NHS ultrasound staff shortage, shows study

World’s first clinical guidance on anal sex after prostate cancer treatments

Researchers propose a new look at the role of ferroptosis in cancer development

Robotic surgery for oropharyngeal cancer not better than radiation therapy, study finds

Three-drug combination could be effective therapy for people with advanced melanoma

ASTRO applauds new prior authorization legislation that aims to reduce obstacles in cancer care

Vitamin D could extend lifespan of cancer patients

Promega launches MSI educational website

MammaPrint and BluePrint identify critical aspects of tumor biology in African-American breast cancer patients

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

Industry Focus eBook - Oncology (3rd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News